ATE216249T1 - Anti-cholesterin ei, impfstoff, herstellungsmethode und verwendung - Google Patents

Anti-cholesterin ei, impfstoff, herstellungsmethode und verwendung

Info

Publication number: ATE216249T1
Authority: AT; Austria
Prior art keywords: eggs; warm; directed; blooded animals; bacterial antigens
Prior art date: 1993-05-26

Application number

AT93916420T

Other languages

English (en)

Inventor

Ralph J Stolle

Lee R Beck

Original Assignee

Dcv Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-05-26

Filing date

1993-05-28

Publication date

2002-05-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22073631&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE216249(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-05-28 Application filed by Dcv Inc filed Critical Dcv Inc

2002-05-15 Application granted granted Critical

2002-05-15 Publication of ATE216249T1 publication Critical patent/ATE216249T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/02—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from eggs
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L15/00—Egg products; Preparation or treatment thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Polymers & Plastics (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Food Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Obesity (AREA)
Epidemiology (AREA)
Hematology (AREA)
Animal Husbandry (AREA)
Zoology (AREA)
Diabetes (AREA)
Nutrition Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Meat, Egg Or Seafood Products (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT93916420T 1993-05-26 1993-05-28 Anti-cholesterin ei, impfstoff, herstellungsmethode und verwendung ATE216249T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6708893A	1993-05-26	1993-05-26
PCT/US1993/005198 WO1994027623A1 (en)	1993-05-26	1993-05-28	Anti-cholesterolemic egg, vaccine and method for production, and use

Publications (1)

Publication Number	Publication Date
ATE216249T1 true ATE216249T1 (de)	2002-05-15

Family

ID=22073631

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93916420T ATE216249T1 (de)	1993-05-26	1993-05-28	Anti-cholesterin ei, impfstoff, herstellungsmethode und verwendung

Country Status (14)

Country	Link
EP (1)	EP0707485B1 (de)
JP (1)	JPH09500870A (de)
AT (1)	ATE216249T1 (de)
AU (1)	AU690521B2 (de)
BR (1)	BR9307851A (de)
CA (1)	CA2163737A1 (de)
DE (1)	DE69331836T2 (de)
DK (1)	DK0707485T3 (de)
ES (1)	ES2177546T3 (de)
FI (1)	FI955692L (de)
IL (1)	IL105845A0 (de)
NO (1)	NO954717L (de)
NZ (1)	NZ254326A (de)
WO (1)	WO1994027623A1 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4357272A (en) *	1978-03-22	1982-11-02	The South African Inventions Development Corporation	Recovering purified antibodies from egg yolk
JPS57144215A (en) *	1981-03-02	1982-09-06	Nippon Nousan Kogyo Kk	Composition for improving lipometabolism
US5215746A (en) *	1982-06-03	1993-06-01	Stolle Research And Development Corporation	Anti-cholesterolemic egg, vaccine and method for production, and use
US4748018A (en) *	1984-02-07	1988-05-31	Stolle Research & Development Corp.	Method of passive immunization of mammals using avian antibody
US4636384A (en) *	1982-06-03	1987-01-13	Stolle Research & Development Corporation	Method for treating disorders of the vascular and pulmonary systems
JPH0651632B2 (ja) *	1985-09-05	1994-07-06	昭和産業株式会社	降コレステロ−ル剤

1993
- 1993-05-28 AT AT93916420T patent/ATE216249T1/de not_active IP Right Cessation
- 1993-05-28 CA CA002163737A patent/CA2163737A1/en not_active Abandoned
- 1993-05-28 AU AU45979/93A patent/AU690521B2/en not_active Ceased
- 1993-05-28 DK DK93916420T patent/DK0707485T3/da active
- 1993-05-28 WO PCT/US1993/005198 patent/WO1994027623A1/en not_active Ceased
- 1993-05-28 EP EP93916420A patent/EP0707485B1/de not_active Expired - Lifetime
- 1993-05-28 NZ NZ254326A patent/NZ254326A/en unknown
- 1993-05-28 ES ES93916420T patent/ES2177546T3/es not_active Expired - Lifetime
- 1993-05-28 FI FI955692A patent/FI955692L/fi unknown
- 1993-05-28 JP JP7500578A patent/JPH09500870A/ja not_active Ceased
- 1993-05-28 DE DE69331836T patent/DE69331836T2/de not_active Expired - Fee Related
- 1993-05-28 BR BR9307851A patent/BR9307851A/pt not_active Application Discontinuation
- 1993-05-30 IL IL105845A patent/IL105845A0/xx unknown
1995
- 1995-11-22 NO NO954717A patent/NO954717L/no unknown

Also Published As

Publication number	Publication date
WO1994027623A1 (en)	1994-12-08
FI955692A0 (fi)	1995-11-24
EP0707485A1 (de)	1996-04-24
NO954717D0 (no)	1995-11-22
DE69331836D1 (de)	2002-05-23
BR9307851A (pt)	1996-03-19
AU4597993A (en)	1994-12-20
EP0707485B1 (de)	2002-04-17
FI955692A7 (fi)	1996-01-24
AU690521B2 (en)	1998-04-30
IL105845A0 (en)	1993-12-28
NO954717L (no)	1996-01-26
JPH09500870A (ja)	1997-01-28
ES2177546T3 (es)	2002-12-16
DE69331836T2 (de)	2002-08-22
NZ254326A (en)	1998-01-26
FI955692L (fi)	1996-01-24
CA2163737A1 (en)	1994-12-08
DK0707485T3 (da)	2002-08-26

Similar Documents

Publication	Publication Date	Title
IL142691A (en)	2010-12-30	Use of an antibody which binds to ailim protein in the manufacture of medicament for preventing, treating or prophylaxis of graft versus host reaction
DE59508825D1 (de)	2000-12-07	Tabakerzeugnisse oder tabakerzeugnissen ähnliche waren mit antioxidativ wirkenden naturstoffen und verfahren zur herstellung derselben
ES2090332T3 (es)	1996-10-16	Tejido linfoide humano en un hospedador inmunocomprometido.
BG104778A (en)	2001-04-30	Antibodies against human cd40
MXPA03009408A (es)	2004-01-29	Factor de crecimiento endotelial vascular 2.
ATE100325T1 (de)	1994-02-15	Verwendung von milch zur herstellung einer hyperimmunmilchverbindung zur behandlung von erkrankungen des atmungssystems bei saeugetieren.
DE69533040D1 (de)	2004-06-17	Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien
ATE522229T1 (de)	2011-09-15	Anti-ngf-antikörper zur behandlung verschiedener erkrankungen
ATE166230T1 (de)	1998-06-15	Verwendung von anti-icam antikörpern zur herstellung eines präparats für die behandlung von endotoxinschock
FI843716A0 (fi)	1984-09-21	Komposition innehaollande pyridinloesligt extrakt och renat detoxifierat endotoxin och anvaendning av densamma.
ATE132703T1 (de)	1996-01-15	Lösliche diätfasernzusammenstellungen und verfahren zur herstellung derselben
US5753268A (en)	1998-05-19	Anti-cholesterolemic egg, vaccine and method for production, and use
BR9809656A (pt)	2000-07-11	Composição imunopotencializante
US5215746A (en)	1993-06-01	Anti-cholesterolemic egg, vaccine and method for production, and use
ATE174959T1 (de)	1999-01-15	Verfahren zur isolierung und kultivierung von transformierten zellen sowie verwendung dieser zellen zur herstellung individuumsspezifischer antikörper
SE7906793L (sv)	1980-02-16	Modifierade grespollenantigener och sett for framstellning derav
DE3483252D1 (de)	1990-10-25	Verfahren zur induktion von antitumorimmunozyten, verfahren zur herstellung von antitumorimmunozyten und durch das verfahren hergestellte antitumorimmunozyten.
ATE307203T1 (de)	2005-11-15	Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
Meenatchisundaram et al.	2008	Studies on pharmacological effects of Russell's viper and Saw-scaled viper venom and its neutralization by chicken egg yolk antibodies
ATE171875T1 (de)	1998-10-15	Entzündungshemmender faktor, verfahren zur isolation und verwendung
ATE43500T1 (de)	1989-06-15	Herstellung von antikoerpern.
DE69331836D1 (de)	2002-05-23	Anti-cholesterin ei, impfstoff, herstellungsmethode und verwendung
DE69426455D1 (de)	2001-01-25	Verfahren zur rekonstitution von rohem fleisch zur herstellung von rekonstituiertem rohfleisch durch zugabe von transglutaminase
ATE359814T1 (de)	2007-05-15	Zusammensetzung, enthaltend bakterielle antigene, zum vorbeugen und behandeln von allergischen erkrankungen
US5849349A (en)	1998-12-15	Anti-cholesterolemic egg, vaccine and method for production, and use

Legal Events

Date	Code	Title	Description
2002-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties